Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure

Kidney International

Volumn 51, Issue 4, 1997, Pages 1170-1181

  Miyata, Toshio ^a   Wada, Yoshinao ^b   Cai, Zhe ^b   Iida, Yoshiyasu ^b   Horie, Katsunori ^b   Yasuda, Yoshinari ^b   Maeda, Kenji ^b   Kurokawa, Kiyoshi ^b   Van Ypersele De Strihou, Charles ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0030902220     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.160     Document Type: Article

References (44)

1. BROWNLEE M, CERAMI A, VLASSARA H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
2. BAYNES JW, MONNIER VM: The Maillard reaction in aging, diabetes and nutrition. Prog Clin Biol Res 304:1-41, 1989
3. ODETTI P, FORGARTY J, SELL DR, MONNIER VM: Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41:153-159, 1992
4. BEISSWENGER PJ, MOORE LL, BRINK-JOHNSEN T: Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217, 1993
5. DYER DG, DUNN JA, THORPE SR, BAILIE KE, LYONS TJ, MCCANCE DR, BAYNES JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin invest 91:2463-2469, 1993
6. KIRSTEIN M, BRETT J, RADOFF S, OGAWA S, STERN D, VLASSARA H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014, 1990
7. VLASSARA H, BROWNLEE M, MANOGUE KR, DINARELLO CA, PASAGIAN A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240:1546-1548, 1988
8. MIYATA T, INAGRI R, IIDA Y, SATO M, YAMADA N, OSA O, MAEDA K, SEO H: Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin 1. J Clin Invest 93:521-528, 1994
9. IIDA Y, MIYATA T, INAGI R, SUGIYAMA S, MAEDA K: β2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 201: 1235-1241, 1994
10. MIYATA T, IIDA Y, UEDA Y, SHINZATO T, SEO H, MONNIER VM, MAEDA K: Monocyte/macrophage response to β2-microglobulin modified with the advanced glycation end products. Kidney Int 49:538-550, 1996
11. SKOLNIK EY, YANG Z, MAKITA Z, RADOFF S, KIRSTEIN M, VLASSARA H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939, 1991
12. MIYATA T, NOTOYA K, YOSHIDA K, HORIE K, MAEDA K, KUROKAWA K, TAKETOMI S: Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol (in press)
13. NEEPER M, SCHMIDT AM, BRETT J, YAN SD, WANG F, PAN YC, ELLISTON K, STERN D, SHAW A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
14. SCHMIDT AM, YON SD, BRETT J, MORA R, NOWYGROD R, STERN D: Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 92:2155-2168, 1993
15. MIYATA T, HORI O, ZHANG JH, YAN SD, FERRAN L, IIDA Y, SCHMIDT AM: The receptor for advanced glycation endproducts mediates the interaction of AGE-β2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: Implication for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 98:1088-1094, 1996
16. BAYNES JW: Perspectives in diabetes: role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
17. YAN SD, SCHMIDT AM, ANDERSON GM, ZHANG J, BRETT J, ZOU YS, PINSKY D, STERN D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9889-9897, 1994
18. YAN SD, YAN FF, CHEN X, JIN F, CHEN M, KUPPUSAMY P, SMITH MA, PERRY G, GODMAN GC, NAWROTH P, ZWEIER JL, STERN D: Nonenzymatically glycated tau in Alzhcimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med 1:693-699, 1995
19. MONNIER VM, SELL DR, NAGARAJ RH, MIYATA S, GRANDHEE S, ODETTI P, IBRAHIM SA: Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41:36-41, 1992
20. MIYATA T, UEDA Y, SHINZATO T, IIDA Y, TANAKA S, KUROKAWA K, VAN YPERSELE DE STRIHOU C, MAEDA K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7:1198-1206, 1996
21. MIYATA T, ODA O, INAGI R, IIDA Y, ARAKI N, YAMADA N, HORIUCHI S, TANIGUCHI N, MAEDA K, KINOSHITA T: β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252, 1993
22. MIYATA T, TANEDA S, KAWAI R, UEDA Y, HORIUCHI S, HARA M, MAEDA K, MONNIER VM: Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93:2353-2358, 1996
23. ε-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889-4894, 1986
24. ε-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry 29:10964-10970, 1990
25. DYER DG, BLACKLEDGE JA, THORPE SR, BAYNES JW: Formation of pentosidine during nonenzymatic browning of protein by glucose: Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 266:11654-11660, 1991
26. WOLFF SP, DEAN RT: Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 245:243-250, 1987
27. HUNT JV, DEAN RT, WOLFF SP: Hydroxyl radical production and autoxidative glycosylation: Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem J 256:205-212, 1988
28. LOUGHREY CM, YOUNG IS, KIGHTBODY JH, MCMASTER D, MCNAMEE PT, TRIMBLE ER: Oxidative stress in haemodialysis. Quart J Med 87:679-683, 1994
29. PEUCHANT E, CARBONNEAU MA, DUBOURG L, THOMAS MJ, PERROMAT A, VALLOT C, CLERC M: Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamins A, E, and iron status. Free Radic Biol Med 16:339-346, 1994
30. CANESTRARI F, GALLI F, GIORGINI A, ALBERTINI MC, GALIOTTA P, PASCUCCI M, BOSSU M: Erythrocyte redox state in uremic anemia: Effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol 91:187-193, 1994
31. YEUNG JH: Effects of glycerol-induced acute renal failure on tissue glutathione and glutathione-dependent enzymes in the rat. Meth Find Exp Clin Pharmacol 13:23-28, 1991
32. WITKO-SARSAT V, FRIEDLANDER M, CAPEILLERE-BLANDIN C, NGUYEN-KHOA T, NGUYEN AT, ZINGRAFF J, JUNGERS P, DESCAMPS-LATSCHA B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313, 1996
33. SELL DR, MONNIER VM: Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264:21597-21602, 1989
34. ε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34:10872-10878, 1995
35. HORIUCHI S, ARAKI N, MORINO Y: Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J Biol Chem 266:7329-7332, 1991
36. MIYATA T, INAGI R, WADA Y, UEDA Y, IIDA Y, TAKAHASHI M, TANIGUCHI N, MAEDA K: Glycation of human β2-microglobulin in patients with hemodialysis-associated amyloidosis: Identification of the glycated sites. Biochemistry 33:12215-12221, 1994
37. ROE JH, MILLS MB, OSTERLING MJ, DAMRON CM: The determination of diketo-l-gulonic acid, dehydro-l-ascorbic acid, and l-ascorbic acid in the same tissue extract by the 2,4-dinitrophenylhydrazine method. J Biol Chem 174:201-208, 1948
38. BENSCH KG, FLEMING JE, LOHMANN WL: The role of ascorbic acid in senile cataract. Proc Natl Acad Sci USA 82:7193-7196, 1985
39. NAGARAJ RH, SELL DR, PRABHAHKARAM M, ORTWERTH BJ, MONNIER VM: High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Natl Acad Sci USA 88:10257-10261, 1991
40. GRANDHEE SK, MONNIER VM: Mechanism of formation of the Maillard protein cross-link pentosidine. J Biol Chem 266:11649-11653, 1991
41. WELLS-KNECHT KJ, ZYZAK DV, LITCHFIELD JE, THORPE SR, BAYNES JW: Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34:3702-3709, 1995
42. PONGOR S, ULRICH PC, BENCSATH FA, CERAMI A: Aging of proteins. Isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc Natl Acad Sci USA 81:2684-2688, 1984
43. NJOROGE FG, SAYRE LM, MONNIER VM: Detection of glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr Res 167:211-220, 1987
44. TAKATA K, HORIUCHI S, ARAKI N, SHIGA M, SAITOH M, MORINO Y: Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins. J Biol Chem 263:14819-14825, 1988